Tauns Laboratories (TSE:197A) Change In Working Capital : 円0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Change In Working Capital?

Tauns Laboratories's change in working capital for the quarter that ended in Dec. 2024 was 円0 Mil.

Tauns Laboratories's change in working capital for the fiscal year that ended in Jun. 2024 was 円1,117 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Tauns Laboratories Change In Working Capital Historical Data

The historical data trend for Tauns Laboratories's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Change In Working Capital Chart

Tauns Laboratories Annual Data

Trend

Jun22

Jun23

Jun24

Change In Working Capital

-305.14

-3,027.48

1,116.64

Tauns Laboratories Quarterly Data
	Jun22	Jun23	Mar24	Jun24	Dec24
Change In Working Capital	-	-	-	-	-

Tauns Laboratories Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Tauns Laboratories Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tauns Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325

Website

https://www.tauns.co.jp/en

Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines